首頁 > 市場調查報告書 > 製藥

藥物開發以基因為基之藥物開發生物標記

市場調查報告書

商品編碼

1907959

異種移植市場：依異種移植類型、動物來源物種、應用、器官類型、免疫抑制通訊協定、最終使用者和地區分類

Xenotransplantation Market, By Type of Xenotransplantation, By Source Animal Species, By Application, By Type of Organ, By Immunosuppressive Protocols, By End User, By Geography

出版日期: 2025年12月26日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

異種移植市場預計在 2026 年達到 32.1 億美元，預計到 2033 年將達到 62.2 億美元，2026 年至 2033 年的複合年成長率為 9.95%。

分析範圍		分析詳情
基準年	2025	市場規模（2025 年）	32.1億美元
效能數據	2021-2024	預測期	2026-2033
預測期（2025-2032 年）複合年成長率	9.90%	預計金額（2032 年）	62.2億美元

全球異種移植市場代表著移植醫學領域的創新前沿，它透過將基因改造的動物器官（主要來自豬）移植到人類受體體內，來解決人類器官嚴重短缺的問題。這個新興領域結合了先進的基因工程技術（包括CRISPR-Cas9基因編輯）和精密的免疫抑制療法，以克服物種特異性的生物屏障和免疫排斥機制。

異種移植涵蓋多種器官類型，包括心臟、腎臟、肝臟、肺臟和胰島，為全球數百萬末期器官衰竭患者提供了潛在的解決方案。該市場涉及眾多相關人員，包括專注於基因改造的生物技術公司、開發免疫抑制通訊協定的製藥企業、開展臨床前和臨床試驗的研究機構以及製定安全框架的監管機構。近期的突破性進展，例如在臨床環境中成功進行的豬到人的心臟和腎臟移植，證明了這項技術的可行性，同時也凸顯了持續研發的必要性。該市場的特點是對基因工程平台、無病原體供體動物的研發以及器官保存技術的進步進行了大量投資。

市場動態

全球異種移植市場的主要驅動力是人類器官捐贈者的嚴重短缺。目前，超過10萬美國人在器官移植等待名單上，但每年只有一小部分人能夠接受移植手術。這種情況使得尋找替代器官來源的需求變得迫切。基因工程技術的進步，特別是CRISPR-Cas9等基因編輯工具的應用，使得對供體動物進行精確改造，從而降低免疫抗原性並提高與人類生理的相容性成為可能，進而推動了市場成長。包括心血管疾病、慢性腎臟病和糖尿病併發症在內的終末期器官疾病的日益普遍，以及全球人口老化，都顯著擴大了需要器官移植的潛在患者群體。

生技公司、創業投資和政府資助機構的大量投資支持了廣泛的研發活動，這些活動正在推動基因修飾技術、免疫抑制療法和器官保存方法的創新。

然而，該市場面臨諸多限制因素。複雜的法規結構要求在臨床應用前進行廣泛的安全性和有效性測試，這可能會使市場准入延遲數年。此外，動物福利方面的倫理問題、宗教敏感性以及社會對動物性器官移植的低接受度也阻礙了其廣泛應用。通用感染疾病傳播的風險，包括豬內源性逆轉錄病毒和其他人畜共通病原體，需要全面的篩檢通訊協定和長期的安全監測，這增加了研發成本和監管複雜性。

然而，發展中國家醫療保健支出的成長、對先進醫療技術的接受度提高以及生物技術公司與學術研究機構之間潛在的合作，正在催生新的機會。標準化監管流程的建立、成功的臨床試驗以及無病原體動物飼養設施的進步，為市場擴張和商業性可行性提供了巨大的成長機會。

本報告的主要特點

本報告對全球異種移植市場進行了詳細分析，並給出了預測期（2025-2032 年）的市場規模和複合年成長率，以 2024 年為基準年。
它還重點介紹了各個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
它還提供了有關市場促進因素、限制因素和機會、新產品發布和核准、市場趨勢、區域展望以及主要企業採取的競爭策略的關鍵見解。
根據公司概況、產品系列、主要亮點、財務表現和策略等參數，對全球異種移植市場的主要企業進行了分析。
本報告提供的見解將使負責人和公司經營團隊能夠就未來的產品發布、產品更新、市場擴張和行銷策略做出明智的決策。
《全球異種移植市場》報告涵蓋了該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過用於分析全球異種移植市場的各種策略矩陣更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 亞太其他地區
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第11章競爭格局

United Therapeutics Corporation
eGenesis, Inc.
Novartis AG
Hoffmanna€'La Roche Ltd.
Astellas Pharma, Inc.
Preservation Solutions, Inc.
OrganOX Limited
TransMedic, Pte. Ltd.
Pfizer, Inc.
Makana Therapeutics
Veloxis Pharmaceuticals, Inc.
Bio Med Pvt. Ltd.
United Therapeutics'Revivicor division
Bristola€'Myers Squibb Company
NZeno/Nzeno

第12章分析師建議

機會
分析師觀點
Coherent Opportunity Map (COM)

第13章參考文獻與分析方法

參考
分析方法
關於 Coherent Market Insights

簡介目錄

Product Code: CMI9142

Xenotransplantation Market is estimated to be valued at USD 3.21 Bn in 2026 and is expected to reach USD 6.22 Bn by 2033, expanding at a compound annual growth rate (CAGR) of 9.9% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2025:	USD 3.21 Bn
Historical Data for:	2021 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2025 to 2032 CAGR:	9.90%	2032 Value Projection:	USD 6.22 Bn

The global xenotransplantation market represents a revolutionary frontier in transplantation medicine, addressing the critical shortage of human organs through the use of genetically modified animal organs, primarily from pigs, for transplantation into human recipients. This emerging field combines advanced genetic engineering technologies, including CRISPR-Cas9 gene editing, with sophisticated immunosuppressive therapies to overcome species-specific biological barriers and immune rejection mechanisms.

Xenotransplantation encompasses various organ types including hearts, kidneys, livers, lungs, and pancreatic islets, offering potential solutions for millions of patients worldwide suffering from end-stage organ failure. The market encompasses multiple stakeholders including biotechnology companies specializing in genetic modification, pharmaceutical manufacturers developing immunosuppressive protocols, research institutions conducting preclinical and clinical trials, and regulatory bodies establishing safety frameworks. Recent breakthrough achievements, such as successful pig-to-human heart and kidney transplantations in clinical settings, have demonstrated the feasibility of this technology while highlighting the need for continued research and development. The market is characterized by substantial investments in genetic engineering platforms, development of pathogen-free donor animals, and advancement of organ preservation technologies.

Market Dynamics

The global xenotransplantation market is primarily driven by the severe shortage of human organ donors, with over 100,000 Americans currently on organ waiting lists and only a fraction receiving transplants annually, creating an urgent need for alternative organ sources. Advancing genetic engineering technologies, particularly CRISPR-Cas9 and other gene editing tools, enable precise modification of donor animals to reduce immunogenicity and improve compatibility with human physiology, accelerating market growth. Rising prevalence of end-stage organ diseases, including cardiovascular disorders, chronic kidney disease, and diabetes-related complications, coupled with aging global populations, significantly expands the potential patient pool requiring transplantation solutions.

Substantial investments from biotechnology companies, venture capital firms, and government funding agencies support extensive research and development activities, fostering innovation in genetic modification techniques, immunosuppressive therapies, and organ preservation methods.

However, the market faces significant restraints including complex regulatory frameworks requiring extensive safety and efficacy studies before clinical implementation, potentially delaying market entry by several years. Ethical concerns regarding animal welfare, religious considerations, and public acceptance of animal-to-human organ transplantation create additional barriers to widespread adoption. Risk of cross-species disease transmission, including porcine endogenous retroviruses and other zoonotic pathogens, necessitates comprehensive screening protocols and long-term safety monitoring, increasing development costs and regulatory complexity.

Nevertheless, opportunities emerge from increasing healthcare expenditure in developing regions, growing acceptance of advanced medical technologies, and potential partnerships between biotechnology companies and academic research institutions. The development of standardized regulatory pathways, successful clinical trial outcomes, and advancement in pathogen-free animal breeding facilities present substantial growth opportunities for market expansion and commercial viability.

Key Features of the Study

This report provides in-depth analysis of the global xenotransplantation market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global xenotransplantation market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include United Therapeutics Corporation, eGenesis, Inc., Novartis AG, F. Hoffmann La Roche Ltd., Astellas Pharma, Inc., Preservation Solutions, Inc., OrganOX Limited, TransMedic, Pte. Ltd., Pfizer, Inc., Makana Therapeutics, Veloxis Pharmaceuticals, Inc., Bio Med Pvt. Ltd., United Therapeutics' Revivicor division, Bristol Myers Squibb Company, and NZeno/Nzeno
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global xenotransplantation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global xenotransplantation market

Market Segmentation

Type of Xenotransplantation Insights (Revenue, USD Bn, 2021 - 2033)
- Solid Organ Xenotransplantation
- Cellular Xenotransplantation
- Tissue Xenotransplantation
Source Animal Species Insights (Revenue, USD Bn, 2021 - 2033)
- Pigs
- Non-human Primates
- Others (e.g., Sheep, Cows)
Application Insights (Revenue, USD Bn, 2021 - 2033)
- Organ Transplantation
- Cell and Tissue Transplantation
- Gene Editing Applications
- Regenerative Medicine
Type of Organ Insights (Revenue, USD Bn, 2021 - 2033)
- Heart
- Kidney
- Liver
- Lungs
- Pancreas
- Skin
- Cornea
Immunosuppressive Protocols Insights (Revenue, USD Bn, 2021 - 2033)
- Immunosuppressive Drugs
- Gene Editing to Modify Immune Response
- Pre-transplantation Genetic Modifications
End User Insights (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Research Institutions
- Biotechnology and Pharmaceutical Companie
Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- United Therapeutics Corporation
- eGenesis, Inc.
- Novartis AG
- Hoffmann La Roche Ltd.
- Astellas Pharma, Inc.
- Preservation Solutions, Inc.
- OrganOX Limited
- TransMedic, Pte. Ltd.
- Pfizer, Inc.
- Makana Therapeutics
- Veloxis Pharmaceuticals, Inc.
- Bio Med Pvt. Ltd.
- United Therapeutics' Revivicor division
- Bristol Myers Squibb Company
- NZeno/Nzeno

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Xenotransplantation Market, By Type of Xenotransplantation
- Global Xenotransplantation Market, By Source Animal Species
- Global Xenotransplantation Market, By Application
- Global Xenotransplantation Market, By Type of Organ
- Global Xenotransplantation Market, By Immunosuppressive Protocols
- Global Xenotransplantation Market, By End User
- Global Xenotransplantation Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Xenotransplantation Market, By Type of Xenotransplantation, 2021-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Solid Organ Xenotransplantation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Cellular Xenotransplantation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Tissue Xenotransplantation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Xenotransplantation Market, By Source Animal Species, 2021-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Pigs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Non-human Primates
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others (e.g., Sheep, Cows)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Xenotransplantation Market, By Application, 2021-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Organ Transplantation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Cell and Tissue Transplantation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Gene Editing Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Regenerative Medicine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

7. Global Xenotransplantation Market, By Type of Organ, 2021-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Heart
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Kidney
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Liver
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Lungs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Pancreas
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Skin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Cornea
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

8. Global Xenotransplantation Market, By Immunosuppressive Protocols, 2021-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Immunosuppressive Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Gene Editing to Modify Immune Response
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Pre-transplantation Genetic Modifications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

9. Global Xenotransplantation Market, By End User, 2021-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Research Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Biotechnology and Pharmaceutical Companie
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

10. Global Xenotransplantation Market, By Region, 2021 - 2033, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2026,2029 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Type of Xenotransplantation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source Animal Species, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Type of Organ, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Immunosuppressive Protocols, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Type of Xenotransplantation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source Animal Species, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Type of Organ, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Immunosuppressive Protocols, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Type of Xenotransplantation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source Animal Species, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Type of Organ, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Immunosuppressive Protocols, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Type of Xenotransplantation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source Animal Species, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Type of Organ, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Immunosuppressive Protocols, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Type of Xenotransplantation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source Animal Species, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Type of Organ, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Immunosuppressive Protocols, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Type of Xenotransplantation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source Animal Species, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Type of Organ, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Immunosuppressive Protocols, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

11. Competitive Landscape

United Therapeutics Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
eGenesis, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Hoffmanna€'La Roche Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Astellas Pharma, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Preservation Solutions, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
OrganOX Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
TransMedic, Pte. Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Pfizer, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Makana Therapeutics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Veloxis Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bio Med Pvt. Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
United Therapeutics' Revivicor division
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bristola€'Myers Squibb Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
NZeno/Nzeno
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies